Michael Peter Messina, D.O. Pediatrics Medicare: Medicare Enrolled Practice Location: 63 Pitt St, Sharon, PA 16146 Phone: 724-981-1940 Fax: 724-981-2825 |
Shruti Sastry, M.D Pediatrics Medicare: Medicare Enrolled Practice Location: 63 Pitt St, Sharon, PA 16146 Phone: 724-342-4052 Fax: 724-342-4053 |
Dr. Paul M Chlpka Jr., M.D. Pediatrics Medicare: Not Enrolled in Medicare Practice Location: 585 E State St, Sharon, PA 16146 Phone: 724-346-6494 Fax: 724-346-9380 |
John T Cunningham, MD Pediatrics Medicare: Medicare Enrolled Practice Location: 63 Pitt St, Sharon, PA 16146 Phone: 724-342-4052 Fax: 724-342-4053 |
News Archive
Anacor Pharmaceuticals announced today that it will present a poster and oral presentation on a novel systemic anti-inflammatory candidate, AN6415, at the upcoming 8th Cytokines and Inflammation Conference, taking place January 28-29, 2010 in La Jolla, California.
Cogent Healthcare today announced a new hospital medicine affiliation with 375-bed Seton Medical Center, located in Daly City, Calif., and the Daly City Hospitalist Medical Group, an existing Seton physician group, to develop a distinctive hospitalist care delivery system.
Obesity is associated with insulin resistance and type 2 diabetes, both of which can be significantly improved by weight loss. Gastric bypass and adjustable gastric banding are two bariatric surgery techniques that are frequently used to effect weight loss in obese patients, but it is unclear if the two procedures produce different outcomes.
Authentidate Holding Corp., a worldwide provider of secure Health Information Exchange, workflow management services and telehealth solutions, today announced that it has completed the previously announced sale of certain non-core assets to Star Advisors, LLC, acting on behalf of the principals of Astria Solutions Group, LLC, for approximately $2.4 million. The assets sold by the company include the company's land and building in Schenectady, NY, which was leased by Astria.
An international consortium of genetics experts has issued a consensus statement recommending chromosomal microarray (CMA) as the new standard practice for genetic evaluation of children with unexplained developmental delay, autism or birth defects.
› Verified 5 days ago